20% to 40%.
less than 10%.
60% to 80%.
tetracycline, 2 g PO.
ciprofloxacin, 500 mg PO, plus azithromycin, 1 g PO.
ceftriaxone, 125 mg IM, plus azithromycin, 1 g PO.
ciprofloxacin, 500 mg PO, plus doxycycline, twice daily, for 7 days.
ceftriaxone, 125 mg IM.
can be treated with metronidazole in pregnant women during the second trimester.
like many sexually transmitted diseases is more likely to be asymptomatic in women than in men.
can be harbored in the mouth and rectum.
responds to a single dose of 500 mg of metronidazole.
can be treated twice daily with metronidazole for 7 days but with greater gastrointestinal side effects than the single-dose therapy.
seek marriage counseling.
use condoms indefinitely.
apply one course of 5-fluorouracil empirically.
A woman with recurrent vaginal yeast infections
A man who has a small papillomatous lesion on his shaft
A person who had polymerase chain reaction (PCR)– proven chancroid, treated 5 years ago
A patient with several umbilicated papules consistent with molluscum contagiosum virus in the groin and lower abdomen
A patient suspected of having syphilis
Cervical cancer may be considered an AIDS-defining illness.
Women tend to seek prompt medical attention due to the high probability of symptomatology attributed to STIs.
Urologists can easily differentiate women with urinary tract infections from those with vaginal infections by taking a thorough history of their lower urinary tract symptoms.
Chancroid affects more women than it does men.
Women with herpes simplex virus (HSV) infection are usually easily identified by the presence of vesicular eruptions in the perivaginal area.
erythromycin, azithromycin, ceftriaxone.
ciprofloxacin, cefixime, erythromycin.
erythromycin, penicillin, tetracycline.
metronidazole, tetracycline, amoxicillin.
doxycycline, azithromycin, trimethoprim-sulfamethoxazole.
should immediately begin suppression therapy.
has probably had HSV-1 in the past.
can expect to engage in intercourse safely without risk of transmission as soon as the lesions heal.
may have buccal lesions as well as genital ulcers.
can expect to have fewer recurrences than patients with HSV-1.
positive HIV status may lead to higher false-negative serologic studies.
RPR and VDRL have a high rate of false-positive results.
RPR and VDRL decrease and normalize with successful therapy.
fluorescent treponemal antibody (FTA) should be the initial screening test.
sensitivity for rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) combined is 100% in secondary syphilis.
PCR assay for Haemophilus ducreyi.
viral cultures for HSV.
darkfield microscopy of the specimen scraped from the wound.
serum RPR or VDRL.
vaginal swabs for Chlamydia L1, L2, L3.
ciprofloxacin, 1000 mg PO.
azithromycin, 1 g PO.
ceftriaxone, 125 mg IM.
ciprofloxacin, 500 mg PO.
levofloxacin, 250 mg PO.
confirmatory cultures and serologic studies should be performed whenever possible.
diagnosis can be reliably made by combining the appearance of the ulcer with the characteristic of inguinal adenopathy.
coinfection of STIs occurs in approximately 10% of patients.
sensitivity for identification based on appearance alone is 31% to 35%.
genital ulcers can also result from noninfectious causes.
选择要在Apple App Store上查看的Topgrade应用程序。